Globus Medical Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $3.1B+24.8% YoYTTM through 30 Jun 2026
Net Income $535.4M+419.9% YoYTTM through 30 Jun 2026
Free Cash Flow $755.6MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 67.4% |
| EBITDA Margin | 29.2% |
| Operating Margin | 16.3% |
| Net Margin | 17.0% |
Returns
11.2%ROE
9.8%ROA
12.2%ROIC
Balance Sheet Health
Debt / Equity0.03x
Current Ratio4.26x
Net Debt-$438.6Mnet cash position
Cash & Equivalents$507.7M
Quality Metrics
Altman Z-Score10.14
Piotroski F-Score7 / 9
FCF Margin24.0%
Rule of 4025.8
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $2.9B
Diluted EPS$3.91TTMFY2025: $3.92
Dividend
No dividend
Capital Allocation
R&D Spend$147.1M
Capex Intensity4.9%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Musculoskeletal Solutions | $2.8B | +18.3% | |
| Enabling Technologies | $141M | -8.4% |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.